Chester County News and Community Website
Do you love keeping track of what’s going on in Chester County? Put your knowledge and expertise to use as a MyChesCo community contributor. Learn more >>
WILMINGTON, DE — A new study from ChristianaCare’s Gene Editing Institute shows that disabling a single gene with CRISPR technology can restore chemotherapy sensitivity in lung cancer, a development researchers …
CRISPR Breakthrough Revives Chemo Response in Resistant Lung Tumors, Study Finds Read More
WASHINGTON, D.C. — The federal government is quietly preparing one of the most sweeping overhauls of Medicare policy in years, advancing a slate of proposed and final rules that could …
Medicare Shake-Up: Inside CMS’s Sweeping Plan To Rewrite The Rules For Seniors Read More
NEWARK, DE — CorriXR Therapeutics announced new peer-reviewed findings showing that its CRISPR-based gene-editing approach can resensitize squamous cell lung carcinoma (LUSC) tumors to standard chemotherapy, offering a potential path …
CRISPR Breakthrough Revives Chemo Response in Lung Cancer Models, CorriXR Reports Read More
WASHINGTON, D.C. — The Department of Veterans Affairs said it has eliminated the entire backlog of CHAMPVA applications, ending years of delays for a program that provides health care coverage …
VA Erases Massive CHAMPVA Backlog in Move Affecting Hundreds of Thousands Read More
WILMINGTON, DE — Anti-money laundering and Know Your Customer compliance has become a defining factor in global fundraising, with a new CSC study showing investors are increasingly walking away from …
New CSC Study Shows AML Failures Are Costing Fund Managers Investors at an Alarming Rate Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Itvisma, a new adeno-associated virus vector-based gene therapy for spinal muscular atrophy, extending treatment eligibility to adults and children 2 …
FDA Greenlights First Gene Therapy for Older SMA Patients, Raising Hope Nationwide Read More
KING OF PRUSSIA, PA — Aclipse Therapeutics has entered a clinical collaboration with Mayo Clinic to advance a Phase 2 study of M107, a novel small-molecule drug positioned as the …
Aclipse, Mayo Clinic Team Up on Trial for First Drug Aimed at Halting Gastroparesis Read More
WASHINGTON, D.C. — The Federal Trade Commission finalized a consent order requiring Gateway Services, Inc. and its subsidiary to halt the use and enforcement of sweeping noncompete agreements that barred …
FTC Shatters Nationwide Noncompete Ban in Pet Cremation Industry Read More
PHILADELPHIA, PA — Aramark (NYSE: ARMK) ended fiscal 2025 with one of its strongest performances in nearly two decades, reporting solid revenue gains, record new business, and a dramatically improved …
ICYMI: Aramark Closes 2025 With Surging Revenue, Record Sales Wins, and Stronger Balance Sheet Read More
WASHINGTON, D.C. — The Treasury Department and Internal Revenue Service this week opened a sweeping public comment period on a new federal tax credit tied to K–12 scholarship donations, a …
IRS Unveils New Education Tax Credit, Sparking Big Questions Ahead of 2027 Launch Read More